Testing effectiveness (Phase 2)Study completedNCT00744991What this trial is testingParticipants With Relapsed Cutaneous T-Cell LymphomaWho this might be right forCutaneous T-Cell Lymphoma Eli Lilly and Company 25
Testing effectiveness (Phase 2)UnknownNCT02274584What this trial is testingCAR T Cells Targeting CD30 Positive Lymphomas (4SCAR30273)Who this might be right forLymphomas Peking University 20
Testing effectiveness (Phase 2)Ended earlyNCT01036399What this trial is testingStudy of Lenalidomide (Revlimid) in Patients With Relapsed/Refractory Peripheral T-cell Lymphoma (PTCL) PatientsWho this might be right forPeripheral T-cell Lymphoma University of Bologna 9
Testing effectiveness (Phase 2)UnknownNCT04705090What this trial is testingYY-20394 in Patients With Relapsed or Refractory Peripheral T/NK Cell LymphomaWho this might be right forPTCL Shanghai YingLi Pharmaceutical Co. Ltd. 90
Early research (Phase 1)Study completedNCT01129180What this trial is testingBortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+9 more Pierluigi Porcu 8
Testing effectiveness (Phase 2)Looking for participantsNCT06244368What this trial is testingGVM±R in Patients With Relapsed or Refractory Aggressive NHL.Who this might be right forPeripheral T Cell LymphomaDiffuse Large B-cell Lymphoma Institute of Hematology & Blood Diseases Hospital, China 115
Testing effectiveness (Phase 2)Study completedNCT02106650What this trial is testingPhase II Study of Folotyn With Leucovorin to Prevent/Reduce Mucositis in Patients With Hematological MalignanciesWho this might be right forRelapsed Peripheral T-Cell LymphomaRefractory Peripheral T-Cell Lymphoma Acrotech Biopharma Inc. 36
Not applicableWithdrawnNCT00900120What this trial is testingCollecting and Storing Blood Samples From Patients With CancerWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07724782What this trial is testingMulti-Cohort Study of Zeprumetostat Combinations for Relapsed/Refractory PTCLWho this might be right forPTCL-NOS Tianjin Medical University Cancer Institute and Hospital 33
Testing effectiveness (Phase 2)Study completedNCT01177371What this trial is testingHigh-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin LymphomaWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+70 more Case Comprehensive Cancer Center 13
Large-scale testing (Phase 3)Study completedNCT03703375What this trial is testingEfficacy and Safety of Oral Azacitidine (CC-486) Compared to Investigator's Choice Therapy in Patients With Relapsed or Refractory Angioimmunoblastic T Cell LymphomaWho this might be right forLymphoma, T-Cell Celgene 93
Testing effectiveness (Phase 2)Looking for participantsNCT06854653What this trial is testingPTX 100 in Patients With Relapsed/Refractory CTCLWho this might be right forCTCL Prescient Therapeutics, Ltd. 115
Not applicableStudy completedNCT00079222What this trial is testingVoriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell TransplantationWho this might be right forCancer Jonsson Comprehensive Cancer Center
Large-scale testing (Phase 3)Study completedNCT01482962What this trial is testingAlisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell LymphomaWho this might be right forRelapsed Peripheral T-Cell LymphomaRefractory Peripheral T-Cell Lymphoma Millennium Pharmaceuticals, Inc. 271
Early research (Phase 1)Study completedNCT00569283What this trial is testingDonor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow TransplantWho this might be right forCancer Asan Medical Center 18
Early research (Phase 1)Looking for participantsNCT06934382What this trial is testingAnti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or LymphomaWho this might be right forT-Cell Acute Lymphoblastic Leukemia/Lymphoma Stephan Grupp MD PhD 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07117305What this trial is testingCD7 CAR-T Combined With Autologous Hematopoietic Stem Cell TransplantationWho this might be right forCD7+ LymphomaT Cell Lymphoma Zhengzhou University 38
Early research (Phase 1)Looking for participantsNCT07143929What this trial is testingTo Observe the CD7-targeted CAR-T Therapy in the Treatment of r/r PTCLWho this might be right forCD7 Positive R/R PTCL Peking University People's Hospital 18
Testing effectiveness (Phase 2)Study completedNCT03372057What this trial is testingDuvelisib in Participants With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)Who this might be right forPeripheral T-cell Lymphoma SecuraBio 156
Testing effectiveness (Phase 2)UnknownNCT04745234What this trial is testingMogamulizumab Q4week Dosing in Participants With R/R CTCLWho this might be right forCutaneous T-Cell Lymphoma, RelapsedCutaneous T-Cell Lymphoma Refractory Kyowa Kirin, Inc. 34